Mark Rochman

3.1k citations
51 papers · 1.8k indexed · h-index 25

Impact in

    • Eosinophilic Disorders and Syndromes
  • Immunology top 5%
    • IL-33, ST2, and ILC Pathways
    • Immune Cell Function and Interaction

Papers in

    • Eosinophilic Disorders and Syndromes 20
    • IL-33, ST2, and ILC Pathways 23
    • Galectins and Cancer Biology 2

Mark Rochman

49 papers receiving 1.8k citations

Peers

Mark Rochman
Comparison fields: 5 of 98
  • Rheumatology 569
  • Immunology 754
  • Immunology and Allergy 137
  • Surgery 853
  • Molecular Biology 556
Replace Hiroaki Takatori with:
Hiroaki Takatori Japan
Julie M. Caldwell United States
Agne Antanaviciute United Kingdom
Shaun W. Jackson United States
Bradford L. McRae United States
IG Young Australia
Bouchaïb Lamkhioued Canada
Jill Hénault Canada
Amala Alag United States
Norman A. Staines United Kingdom
Mark Rochman relative to Hiroaki Takatori Japan Hiroaki Takatori's profile →
Citations per field
00.5×2.9×
Hiroaki Takatori · 1×
Citations per year

Countries citing papers authored by Mark Rochman

Since Specialization
Citations

This map shows the geographic impact of Mark Rochman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rochman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rochman more than expected).

Fields of papers citing papers by Mark Rochman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rochman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rochman. The network helps show where Mark Rochman may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Rochman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Rochman Line = papers co-authored together Mark Rochman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019140
2 2016127
3 2015103
4 201894
5 200991
6 201391
7 201775
8 201873
9 201764
10 201361
11 201058
12 200154
13 202149
14 202247
15 201039
16 201438
17 202037
18 201737
19 200237
20 201135

About Mark Rochman

Mark Rochman is a scholar working on Rheumatology, Immunology, Surgery, Immunology and Allergy and Cancer Research, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Eosinophilic Esophagitis (31 papers), IL-33, ST2, and ILC Pathways (23 papers), Eosinophilic Disorders and Syndromes (20 papers), Genomics and Chromatin Dynamics (11 papers), RNA Research and Splicing (8 papers), Asthma and respiratory diseases (4 papers), RNA and protein synthesis mechanisms (3 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Rheumatology (569 citations), Immunology (754 citations), Immunology and Allergy (137 citations), Surgery (853 citations) and Molecular Biology (556 citations). Mark Rochman has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Marc E. Rothenberg, Julie M. Caldwell, Michael Bustin, Jeffrey K. Rymer, Jared Travers, Cédric Malicet, Nurit P. Azouz, Emily M. Stucke, Ting Wen and Leah C. Kottyan. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Nature Communications, JCI Insight, Mucosal Immunology and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026